Wockhardt, in a release issued to the National Stock Exchange on Tuesday, has announced the acquisition of CP Pharmaceuticals (Holdings) along with its subsidiaries.

CP Pharmaceuticals is based in Wrexham, United Kingdom.

The stock was up nearly 7% (Rs 25) at Rs 409 on the NSE at 1445 hours.